News
6d
Zacks Investment Research on MSNAlnylam Wins EC Nod for Label Expansion of Amvuttra for ATTR-CMAlnylam Pharmaceuticals, Inc. ALNY announced that the European Commission (EC) has approved a label expansion of its RNAi ...
Bristol Myers Squibb BMY announced that the European Commission (EC) approved a label expansion of the immuno-oncology drug Opdivo (nivolumab). The EC approved the drug as a monotherapy for the ...
Alnylam Pharmaceuticals, Inc. ALNY announced that the European Commission (EC) has approved a label expansion of its RNAi therapeutic Amvuttra. The EC has now approved Amvuttra for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results